about
Development, characterization and application of monoclonal antibodies against Brazilian Dengue virus isolatesMEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virusDengue Fever: Causes, Complications, and Vaccine StrategiesThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseLatest developments and future directions in dengue vaccinesDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesDengueME: A Tool for the Modeling and Simulation of Dengue Spatiotemporal DynamicsPrecisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody ResponsesEnhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013Cyclooxygenase‐2 facilitates dengue virus replication and serves as a potential target for developing antiviral agentsGenetically modified organisms and visceral leishmaniasisRapid diagnostic tests for dengue virus infection in febrile Cambodian children: diagnostic accuracy and incorporation into diagnostic algorithms.Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patientsDengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation.Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals.Dengue vaccine: come let's fight the menace.Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials.A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.Reduction in dengue cases observed during mass control of Aedes (Stegomyia) in street catch basins in an endemic urban area in Colombia.In Silico Screening, Alanine Mutation, and DFT Approaches for Identification of NS2B/NS3 Protease Inhibitors.Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.Recent progress in dengue vaccine development.Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.Recent advances in the production of recombinant subunit vaccines in Pichia pastoris.Widespread signatures of local mRNA folding structure selection in four Dengue virus serotypes.Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection.Rare case of acute dengue encephalitis with correlated MRI findings.Adult-onset, chronic, cyclic thrombocytopenia in a Rhesus macaque (Macaca mulatta) after dengue virus vaccination and viral challenge.
P2860
Q24288673-958D2CED-4C9D-40BE-9FDD-28E48B23686AQ26700001-388EC0B6-7FCB-4A57-BAA3-8777328DDE08Q26700082-9D4277E0-97AD-4683-8AB5-B1B31871DA19Q26995782-79D1A926-FE12-4863-B549-6F031B40021FQ27023422-C428FD97-FBC1-4EF3-A44D-433AB857843EQ27304342-7DF09608-FB59-48C0-B1D2-EB3FF862398AQ27468688-22FE5909-5D44-438F-9258-42DDABDC7B1BQ27493140-511EED01-0E16-4248-B422-D6B1A2A41FFDQ28654939-BAD5D7F0-89DA-400C-94E6-9F415B74AB93Q28974151-56C29CF3-802D-4C63-959B-796EAC998D9CQ33647026-456CA1CF-2D3C-486A-BEAF-53FEF0DC0014Q35120222-87124F27-91E3-465D-B678-959FE7594225Q35590817-2349EDD8-E295-4FC0-AB19-C03FBBB7471BQ35880303-C6F9EFBB-CF7E-4875-8A01-459F42343A57Q35886539-CCF4F0DA-B6DF-47DA-A1BA-7F3B14880E74Q35887206-A35E50CB-E505-45AC-9FA2-4E094B896E1CQ36085940-1A1EB9C5-1CB3-4565-9CC0-0CC12761629DQ36205859-C509611A-CDC9-4FE0-A35F-C932F4C98829Q36303004-BF59229A-A457-4601-B659-0326FCD0C9AAQ36670319-146E2C80-1114-4DE1-B662-570D4BA20181Q37265013-DCBDF4DF-325E-4535-B323-69081B56FDBFQ38303232-65EEB63D-0FF9-49B0-AEBB-143A6147AF81Q38614539-11283AA4-CA7A-43B3-ADAA-4494C662BA5AQ38786420-D029F6B1-A05F-401D-AD94-2AACB9E9C1F2Q38849581-A8C1A133-1722-4D95-AFF6-906DA4111720Q38955198-CD2F19CF-9404-4CD3-A2DD-F0D867CBAD29Q40045064-A65E92C9-585E-4EE5-9915-F0ED2C31A67DQ40209146-48D7CBD1-C4A2-4BC4-BCCD-C9A095D8875FQ45328827-4F455587-C794-48DC-A21A-D9BFF76D6D5D
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Current progress in dengue vaccines
@ast
Current progress in dengue vaccines
@en
type
label
Current progress in dengue vaccines
@ast
Current progress in dengue vaccines
@en
prefLabel
Current progress in dengue vaccines
@ast
Current progress in dengue vaccines
@en
P2093
P2860
P356
P1476
Current progress in dengue vaccines
@en
P2093
Chiou-Feng Lin
Hsiao-Sheng Liu
Robert Anderson
Shu-Wen Wan
Shuying Wang
Yee-Shin Lin
P2860
P2888
P356
10.1186/1423-0127-20-37
P5008
P577
2013-06-13T00:00:00Z
P5875
P6179
1033950825